Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus MeetingNiven Mehra, Margreet G.E.M. Ausems, Iris S. H. Kloots et al.|European Urology Open Science|2023Cited by 10
PD52-02 FGFR3 MUTATIONS AND THEIR RELATION TO FGFR3 EXPRESSION AND CLINICAL OUTCOME IN A LARGE RADICAL CYSTECTOMY COHORT: IMPLICATIONS FOR ANTI-FGFR3 BLADDER CANCER TREATMENT?Bas van Rhijn, T.C.M. Zuiverloon, Laura S. Mertens et al.|The Journal of Urology|2019Cited by 0
Molecular markers (FGFR3 mutation; p53 and Ki-67 expression) and clinical outcome of radical cystectomy for bladder cancer: A multi-center, multi-laboratory studyBas W.G. van Rhijn, Tahlita C.M. Zuiverloon, Geert van Leenders et al.|European Urology Supplements|2019Cited by 0
Abstract B23: <i>FGFR3</i> mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?Bas van Rhijn, Tahlita C.M. Zuiverloon, Laura S. Mertens et al.|Clinical Cancer Research|2020Cited by 0